Eli Lilly vs. Novo Nordisk: Fortunes Diverge for the Weight-Loss Drug Titans - The Wall Street Journal
Business
The weight-loss drug market is booming but the spoils arent being shared equally. Shares of Eli Lilly jumped more than 10% Wednesday. That came after the company reported better-than-expected quart? [+402 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Popular Categories

Stay Connected

Loading...